Evaluation of immunomodulatory effects of lomefloxacin in mice
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 56
Abstract
Lomefloxacin is a flouroquinolone antibiotic that is quite efficacious against many gram negative and gram positive pathogens. Lomefloxacin evince antibacterial effects by modifying DNA gyrase in gram negative pathogens and topoisomerase IV in gram positive pathogens. This study is designed to assess the immunomodulatory effects of lomefloxacin in male albino mice. Three doses of lomefloxacin 12.5 mg/kg, 25 mg/kg and 50 mg/kg were used and delayed type hypersensitivity assay, cyclophosphamide induced neutropenic assay, carbon clearance assay, heamagglutination assay and mice lethality test were performed to evaluate the effects of lomefloxacin on immune system of mice. DTH assay has depicted the significant immunosuppressant potential of lomefloxacin at 25 mg/kg and 50 mg/kg dose. Total leukocyte count have exhibited highly significant reduction (P<0.001) in leukocyte count after cyclophosphamide administration. Differential leukocyte count has shown significant (P<0.01) reduction in lymphocyte count, whereas, highly significant (P<0.001) increase in monocyte count and significant (P<0.05) increase neutrophil count has been observed. In carbon clearance assay, highly significant (P<0.01) increase in phagocytic index has been noted at 12.5 mg/kg and 25 mg/kg doses. Humoral immune system responses are suppressed in dose dependent manner by both heamagglutination assay (P<0.001) and mice lethality assay (P<0.001). Results clearly depict that lomefloxacin possess quite significant immunomodulatory potential.Keywords
This publication has 18 references indexed in Scilit:
- Monocytes and Macrophages Regulate Immunity through Dynamic Networks of Survival and Cell DeathJournal of Innate Immunity, 2010
- Pasteurella multocida Toxin Activates Various Heterotrimeric G Proteins by DeamidationToxins, 2010
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008
- Effect of ivermectin on the cellular and humoral immune responses of rabbitsLife Sciences, 2007
- Experimental Mouse Lethality ofEscherichia coliIsolates, in Relation to Accessory Traits, Phylogenetic Group, and Ecological SourceThe Journal of Infectious Diseases, 2006
- Pasteurella multocida Toxin Type D Serological Assay as an Alternative to the Toxin Neutralisation Lethality Test in MiceBiologicals, 2001
- The FluoroquinolonesMayo Clinic Proceedings, 1999
- The Future of the QuinolonesDrugs, 1999
- Structure-activity relationships of the fluoroquinolonesAntimicrobial Agents and Chemotherapy, 1989